Compare OCCI & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | OCCI | BHST |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.6M | 39.0M |
| IPO Year | 2017 | 2017 |
| Metric | OCCI | BHST |
|---|---|---|
| Price | $1.62 | $1.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | ★ 265.7K | 15.9K |
| Earning Date | 12-11-2023 | 11-12-2026 |
| Dividend Yield | ★ 24.32% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.44 |
| Revenue Next Year | $10.19 | $32.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.40 | $1.37 |
| 52 Week High | $5.15 | $9.75 |
| Indicator | OCCI | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 30.35 | 48.00 |
| Support Level | N/A | $1.40 |
| Resistance Level | $2.68 | $1.77 |
| Average True Range (ATR) | 0.11 | 0.15 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 31.02 | 42.18 |
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.